Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes
Xuqing Zhang(Army Medical University), Mark J. Macielag(Springhouse), Lisa Norquay(Springhouse), Lili Guo(Henan University of Science and Technology), George Ho(Springhouse), Ivona Bakaj(Springhouse), Bin Zhu(Springhouse), Seunghun P. Lee(Springhouse), Matthew M. Rankin(Janssen (United States)), Jack A. Kauffman(Springhouse)
Cited by 6
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Growth and Regeneration of Adult β Cells Does Not Involve Specialized Progenitors
|Developmental Cell|2007|551
Very Slow Turnover of β-Cells in Aged Adult Mice
|Diabetes|2005|465
Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age
|Diabetes|2009|322
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies
|Cell Metabolism|2022|255